WuXi Healthcare Ventures, a corporate venture arm owned by China-based WuXi PharmaTech, has closed its second early-stage healthcare fund at $290 million, exceeding the target of $200 million.
A PE-backed consortium that includes Meinian Onehealth has submitted a revised and improved proposal to acquire US-listed iKang Healthcare Group.
The Goldstone Investment-managed CITIC M&A Fund and Legend Capital have led a $280 million round of financing for Pharmaron, a Chinese contract research organization (CRO) company.
Yirendai, an online peer-to-peer (P2P) online platform owned by China-based micro-credit loan player CreditEase, is looking to raise up to $82.5 million through its US IPO.
Tsinghua Unigroup, an investment arm of China’s Tsinghua University, is planning to spend $2.1 billion to acquire stakes in two Taiwanese semiconductor testing and packaging companies.
A consortium comprising the founder and CEO of WuXi PharmaTech and several PE investors has completed the privatization of the China-based provider of contract R&D services to global pharmaceutical companies.
Hunan TV & Broadcast Intermediary, a Shenzhen-listed TV producer, will invest up to RMB300 million ($46.7 million) in a project fund raised to support the take-private of Chinese internet security firm Qihoo 360 Technology.
Olympus Capital has committed $45 million to Li Tong Group (LTG), a Hong Kong-based reverse supply chain services provider and electronic waster (e-waste) processor.
Maidai Licai and China Top Credit, two Chinese online finance platforms wholly-owned by CITIC Private Equity, have raised RMB420 million ($65 million) from their parent company and other strategic investors.
Chinese budget hotel operator Home Inns and online dating site Jiayuan have agreed to be taken private and merge with industry counterparts.
Morgan Stanley Private Equity Asia (MSPEA) has agreed to sell its 38.7% stake in Sino Gas to Zhongyu Gas. The buyer participated alongside MSPEA in the privatization of Sino Gas last year and will now take a majority stake in the business.
As founder and chairman of H&Q Asia Pacific, Ta-Lin Hsu has played a key role in the development of private equity in Asia. He continues to look for ways to spread innovation
Neil Shen, managing partner of Sequoia Capital China, on identifying stand-out entrepreneurs and the competitive dynamics of a maturing start-up ecosystem
As corporate China adjusts to a slower growth environment, Ascendent Capital Partners’ strategy of providing advice alongside capital resonated with LPs
Having raised $3 billion in the largest-ever private funding round for a start-up, newly-merged Didi Kuaidi is looking to put past rivalries behind it
Set up in 2013, Banyan Capital got busy quickly in China’s early-stage space and is now managing its second US dollar fund, which closed at $362 million
China-based electric scooter manufacturer Ninebot made an aggressive move into the US with the purchase of Segway. VCs were happy to support the deal
Bain Capital enjoyed its most active year in Asia as positive experiences from previous deals and proactive engagement with entrepreneurs helped deliver a string of new investments
Canada Pension Plan Investment Board (CPPIB) and Temasek Holdings have participated in a RMB45.1 billion ($7.5 billion) pre-IPO funding round for The Postal Savings Bank of China (PSBC)
Cathay Capital Private Equity has led a Series D round of funding for Meet You, a Chinese social networking platform for women.
The International Financial Corporation (IFC), the private investment arm of the World Bank, plans to invest $25 million in the latest fund raised by SBCVC, previously known as SoftBank China Venture Capital.
Sequoia Capital has led a $84 million Series C round of funding for Xiaozhan Jiaoyu, a Chinese online education platform that focuses on students studying abroad.
Ride-hailing apps including India's Ola, China's Didi Kuaidi, Southeast Asia's GrabTaxi and US-based Lyft have announced a strategic global partnership.
Archer Capital has agreed to sell Healthe Care, Australia’s third-largest private hospital group, to China-based Luye Medical Group, for $688 million. CITIC Private Equity is a shareholder in the company’s Hong Kong-listed affiliate, Luye Pharma.